Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phoenix Brio is a medical device holding and operating company, recently acquiring Arthrosurface from Anika Therapeutics for $10 million in October 2024. The company is focused on innovative orthopedic and surgical devices, acting as parent to Arthrosurface and sharing its headquarters in West Bridgewater, Massachusetts. Clinical results are not directly reported as Phoenix Brio serves in a corporate and operating role rather than a therapeutics development one.[1][3][5][7][8][9]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phoenix Brio.